YODA
Research type
Research Study
Full title
The Impact of Real-time Continuous Glucose Monitoring on Glycaemic Control in High-risk Adolescents and Young Adults with Insulin-treated Diabetes
IRAS ID
256276
Contact name
Shivani Misra
Contact email
Sponsor organisation
Imperial College London
Duration of Study in the UK
1 years, 6 months, 1 days
Research summary
There is a clinical need to identify strategies that can address control in high-risk young-adult populations with type 1 diabetes (T1DM) who are at risk of frequent hospital admissions. As real time continuous glucose monitoring (RT-CGM) devices have evolved and with increasing acceptability of wearable technology it is possible that groups within this specific age bracket may derive benefit from RT-CGM, overlooked in studies to date. Recruitment will be undertaken from the Young Adult Diabetes clinics (18-23 year olds) at Imperial College Healthcare NHS Trust and from the adult diabetes clinics at Imperial College Healthcare NHS Trust. Participant information sheets will be given to potential subjects and, following any questions, informed consent will be taken. 12 months per participant. Total study duration = 18 months. RT-CGM is a continuous glucose monitor that measures glucose concentration and alarms when levels are too low or too high. Participants will receive either RT-CGM or standard care (self monitoring blood glucose) and then crossover. We will assess the impact of RT-CGM on their diabetic control.
REC name
London - London Bridge Research Ethics Committee
REC reference
19/LO/1341
Date of REC Opinion
29 Oct 2019
REC opinion
Further Information Favourable Opinion